Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board, at its meeting on May 5, 2025, approved converting 5.5 crore convertible warrants into an equal number of equity shares of Rs. 1 face value. These warrants were originally allotted on November 13, 2024 at Rs. 7.40 each (Rs. 1 face value + Rs. 6.40 premium) on a preferential basis. With this conversion, the company received Rs. 30.52 crore as the remaining 75% of the issue price. Two allottees converted their warrants: Unico Global Opportunities Fund (2.5 crore shares) and Al Maha Investment Fund PCC-Onyx Strategy (3 crore shares), while Forbes EMF did not participate in this tranche. Following the allotment, the company's paid-up equity share capital rose to Rs. 49.45 crore, comprising 49.45 crore shares. About 7.4 crore warrants are still pending conversion in future tranches.
Existing shareholders face dilution as 5.5 crore new shares are added to the share base, with another 7.4 crore warrants yet to be converted — meaning further dilution could come later. On the positive side, the company strengthens its capital base with Rs. 30.52 crore of fresh funds coming in. Stock price may see short-term pressure from the increased share supply, especially given the small size of the company.